pioglitazone has been researched along with Leucocythaemia in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghasemi, H | 1 |
| Jamshidi, A | 1 |
| Ghatee, MA | 1 |
| Mazhab-Jafari, K | 1 |
| Khorasani, M | 1 |
| Rahmati, M | 1 |
| Mohammadi, S | 1 |
| Saiki, M | 1 |
| Hatta, Y | 1 |
| Yamazaki, T | 1 |
| Itoh, T | 1 |
| Enomoto, Y | 1 |
| Takeuchi, J | 1 |
| Sawada, U | 1 |
| Aizawa, S | 1 |
| Horie, T | 1 |
2 other studies available for pioglitazone and Leucocythaemia
| Article | Year |
|---|---|
PPARĪ³ activation by pioglitazone enhances the anti-proliferative effects of doxorubicin on pro-monocytic THP-1 leukemia cells via inducing apoptosis and G2/M cell cycle arrest.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; | 2022 |
Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells.
Topics: Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Erythroid Precursor Cells; H | 2006 |